Senseonics
$7.24
428
+$0.06+0.84% Today
Statistics
Day High
7.43
Day Low
7.13
52W High
12.58
52W Low
4.79
Volume
421,555
Avg. Volume
710,157
Mkt Cap
302.41M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Expected EPS
-0.613371
Actual EPS
N/A
Financials
-196.03%Profit Margin
Unprofitable70.51MRevenue
-138.23MNet Income
Analyst Ratings
11.00Average Price Target
The highest estimate is 14.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SENS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap29.08B
Abbott Laboratories
ABT
Mkt Cap153.59B
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Insulet
PODD
Mkt Cap10.37B
Medtronic
MDT
Mkt Cap102.97B
Mirum Pharmaceuticals
MIRM
Mkt Cap5.7B
Novo Nordisk
NVO
Mkt Cap194.35B
Sanofi
SNY
Mkt Cap105.92B
Merck
MRK
Mkt Cap294.03B
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
About
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Show more...
CEO
Dr. Timothy T. Goodnow Ph.D.
Employees
117
Country
United States
ISIN
US81727U3032
Listings
0 Comments
Share your thoughts
FAQ
What is Senseonics stock price today?▼
The current price of SENS is $7.24 USD — it has increased by +0.84% in the past 24 hours. Watch Senseonics stock price performance more closely on the chart.
What is Senseonics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Senseonics stocks are traded under the ticker SENS.
Is Senseonics stock price growing?▼
SENS stock has risen by +1.54% compared to the previous week, the month change is a +25.48% rise, over the last year Senseonics has showed a -27.86% decrease.
What is Senseonics market cap?▼
Today Senseonics has the market capitalization of 302.41M
When is the next Senseonics earnings date?▼
Senseonics is going to release the next earnings report on August 06, 2026.
What were Senseonics earnings last quarter?▼
SENS earnings for the last quarter are -0.71 USD per share, whereas the estimation was -0.69 USD resulting in a -3.57% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Senseonics revenue for the last year?▼
Senseonics revenue for the last year amounts to 70.51M USD.
What is Senseonics net income for the last year?▼
SENS net income for the last year is -138.23M USD.
How many employees does Senseonics have?▼
As of June 15, 2026, the company has 117 employees.
In which sector is Senseonics located?▼
Senseonics operates in the Health & Wellness sector.
When did Senseonics complete a stock split?▼
The last stock split for Senseonics was on October 20, 2025 with a ratio of 1:20.
Where is Senseonics headquartered?▼
Senseonics is headquartered in Germantown, United States.